AmyPore Company
AmyPore develops an innovative drug that targets a common mechanism of Alzheimer's and Parkinson's diseases.
Founded Date:
2018-01-01
Last Funding Type:
Non-equity Assistance
Headquarters:
Septèmes-les-vallons, Provence-Alpes-Cote d'Azur, France
Investors Number:
2
Employee Number:
1-10
Industry:
Neurodegeneration and Aging
Last Funding Date:
2019-04-03
Total Funding:
81868